Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials

Wei‐Xiang Qi(Shanghai Jiao Tong University), Lina Tang(Shanghai Sixth People's Hospital), Aina He(Shanghai Sixth People's Hospital), Yang Yao(Shanghai Sixth People's Hospital), Zan Shen(Shanghai Jiao Tong University)
International Journal of Clinical Oncology
April 19, 2013
10.1007/s10147-013-0561-6
Cited by 203

Abstract

Related Papers

Operating Characteristics of a Rank Correlation Test for Publication Bias
Colin B. Begg, Madhuchhanda Mazumdar|Biometrics|1994|17k
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Salim Yusuf, Richard Peto, John A. Lewis et al.|Progress in Cardiovascular Diseases|1985|3.2k
Skeletal complications of malignancy
Robert E. Coleman|Cancer|1997|1.4k
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew Smith, Blair Egerdie, Narciso Hernández Toriz et al.|New England Journal of Medicine|2009|1.1k
Epidemiology and pathogenesis of osteonecrosis of the jaw
Ian R. Reid, Jillian Cornish|Nature Reviews Rheumatology|2011|179